Expression and prognosis analysis of DNMT family in acute myeloid leukemia
Ting‐juan ZhangDepartment of Hematology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, JiangsuPeople’s Republic of ChinaLiu-chao ZhangDepartment of Medical Laboratory, Shanghai Deji Hospital, Qingdao University, Shanghai, People’s Republic of ChinaZi‐jun XuLaboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of ChinaJing‐dong ZhouDepartment of Hematology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, JiangsuPeople’s Republic of China
2020en
ABI
Аннотация
expression acted as a potential prognostic biomarker and may guide treatment choice between chemotherapy and HSCT in AML.
Ҳали таржима қилинмаган
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба